Abstract
A patient with renal failure and insulin-dependent diabetes received renal and segmental pancreatic allografts from the same donor, with exocrine drainage of the pancreas being directed into the bowel. An attempt was made to maintain the serum concentrations of cyclosporin A between 300 and 1000 μg/l to avoid serious nephrotoxicity and rejection. Considerable difficulty was experienced in controlling the serum concentrations even with continuous intravenous infusion. When the concentrations were maintained between 300 and 1000 μg/l function in both allografts was satisfactory.
At seven months the patient required no insulin and had good renal function. He was not receiving corticosteroids.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Calne R. Y., Rolles K., White D. J., Thiru S., Evans D. B., Henderson R., Hamilton D. L., Boone N., McMaster P., Gibby O. Cyclosporin-A in clinical organ grafting. Transplant Proc. 1981 Mar;13(1 Pt 1):349–358. [PubMed] [Google Scholar]
- Calne R. Y., Rolles K., White D. J., Thiru S., Evans D. B., McMaster P., Dunn D. C., Craddock G. N., Henderson R. G., Aziz S. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet. 1979 Nov 17;2(8151):1033–1036. doi: 10.1016/s0140-6736(79)92440-1. [DOI] [PubMed] [Google Scholar]
- Dubernard J. M., Traeger J., Neyra P., Touraine J. L., Tranchant D., Blanc-Brunat N. A new method of preparation of segmental pancreatic grafts for transplantation: trials in dogs and in man. Surgery. 1978 Nov;84(5):633–639. [PubMed] [Google Scholar]
- Hows J. M., Gordon-Smith E. C. Nephrotoxicity of cyclosporin A. Lancet. 1981 Oct 17;2(8251):876–877. doi: 10.1016/s0140-6736(81)91142-9. [DOI] [PubMed] [Google Scholar]
- Keown P. A., Stiller C. R., Ulan R. A., Sinclair N. R., Wall W. J., Carruthers G., Howson W. Immunological and pharmacological monitoring in the clinical use of cyclosporin A. Lancet. 1981 Mar 28;1(8222):686–689. doi: 10.1016/s0140-6736(81)91971-1. [DOI] [PubMed] [Google Scholar]